European Commission approves VYLOY (zolbetuximab) + chemo combo for 1L HER2-neg, CLDN 18.2 +ve gastric/GEJ adenocarcinoma September 25, 2024
Nona Biosciences Enters Strategic Collaboration with Alkyon Therapeutics for Next-Gen Immunotherapeutics Discovery September 25, 2024
